Table 1 Baseline sociodemographic and illness- and treatment-related characteristics of a sample of employees undergoing chemotherapy for cancer, working/at part time sick leave or at full time sick leave at baseline. Mean and standard deviation, median and interquartile range, 95% confidence interval, frequency and percentage, and p-values
Working / at part time sick leave (N = 82) | At full time sick leave (N = 135) | ||
|---|---|---|---|
Mean (SD) / Median (IQR) | Mean (SD) / Median (IQR) | P-value | |
Age (years), mean (SD) | 52 (7.10) | 50 (7.34) | 0.063 |
Missing | 0 | 0 | |
Time since diagnosis (days), median (IQR) | 71.50 (48–98) | 72.00 (49–96) | 0.900 |
Missing | 0 | 0 | |
Time since initiation of chemotherapy (days), mean (SD) | 32 (18.71) | 34 (19.55) | 0.536 |
Missing | 0 | 0 | |
Perceived support from the work place a, mean (SD) | 9.23 (1.73) | 8.57 (2.31) | 0.051 |
Missing | 20 | 11 | |
N (%) | N (%) | ||
Gender | 0.056 | ||
Female | 52 (63) | 102 (76) | |
Man | 30 (37) | 33 (24) | |
Missing | 0 (0) | 0 (0) | |
Ethnicity | 0.203 | ||
Danish | 76 (93) | 125 (93) | |
Other | 0 (0) | 4 (3) | |
Missing | 6 (7) | 6 (4) | |
Educational level | 0.425 | ||
None | 7 (8) | 12 (9) | |
Short | 40 (49) | 53 (39) | |
Medium | 21 (26) | 48 (36) | |
Long | 10 (12) | 19 (14) | |
Missing | 4 (5) | 3 (2) | |
Work type | 0.130 | ||
Physical | 14 (17) | 35 (26) | |
Sedentary | 42 (51) | 53 (39) | |
Mixed | 20 (25) | 41 (30) | |
Missing | 6 (7) | 6 (5) | |
Self-employed | 0.002 | ||
Yes | 13 (16) | 5 (4) | |
No | 63 (77) | 124 (92) | |
Missing | 6 (7) | 6 (4) | |
Leadership | 0.024 | ||
Yes | 21 (26) | 19 (14) | |
No | 55 (67) | 110 (82) | |
Missing | 6 (7) | 6 (4) | |
Marital status | 0.851 | ||
Married | 60 (73) | 106 (79) | |
Living with parents | 0 (0) | 0 (0) | |
Widower | 1 (1) | 1 (1) | |
Divorced | 12 (15) | 19 (14) | |
Have always lived alone | 3 (4) | 3 (2) | |
Missing | 6 (7) | 6 (4) | |
Children living at home | 0.569 | ||
No | 41 (50) | 59 (44) | |
Yes | 35 (43) | 68 (50) | |
Missing | 6 (7) | 8 (6) | |
Type of cancer | 0.645 | ||
Female reproductive system | 3 (4) | 8 (6) | |
Breast | 42 (51) | 69 (51) | |
Lung incl. Mesotheliomas | 5 (6) | 11 (8) | |
Urological incl. Male reproductive system | 8 (10) | 5 (4) | |
Upper gastrointestinal | 8 (10) | 13 (10) | |
Colorectal | 7 (8) | 17 (12) | |
Cerebral and the central nervous system | 5 (6) | 5 (4) | |
Other | 4 (5) | 7 (5) | |
Missing | 0 (0) | 0 (0) | |
Treatment intention | 0.333 | ||
Curative | 59 (72) | 105 (78) | |
Palliative | 23 (28) | 30 (22) | |
Missing | 0 (0) | 0 (0) | |
Treatment modalities | 0.864 | ||
Chemotherapy | 64 (78) | 109 (81) | |
Chemotherapy and one additional treatment modality | 16 (20) | 22 (16) | |
Chemotherapy and two additional treatments modalities | 2 (2) | 4 (3) | |
Missing | 0 (0) | 0 (0) |